Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quynh Chi Le

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Molecular Phylogenetics and Evolution|February 1, 2012
Comparison of Boolean analysis and standard phylogenetic methods using artificially evolved and natural mt-tRNA sequences from great apesEszter Ari, Péter Ittzés, János Podani, et al.
Urologie (Heidelberg, Germany)|December 29, 2023
[Urinary diversion with or without simple cystectomy as a salvage option for benign diseases of the lower urinary tract]Malin A Lutz, Quynh Chi Le, Matthias Müller, et al.
Biology|October 23, 2021
Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer CellsIgor Tsaur, Anita Thomas, Eva Juengel, et al.
The Prostate|January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical ProstatectomyCarolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Urologia Internationalis|March 6, 2024
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial CarcinomaSéverine Banek, Mike Wenzel, Benedikt Lauer, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2025
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable modelCarolin Siech, Helge von Kriegstein, Mike Wenzel, et al.
European Urology Oncology|May 29, 2025
Influence of Concomitant Androgen Deprivation Therapy and Its Duration for Salvage Radiation After Radical Prostatectomy: A Systematic Review and Network Meta-analysis According to Published DataQuynh Chi Le, Carolin Siech, Benedikt Hoeh, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Molecular Phylogenetics and Evolution|February 1, 2012
Comparison of Boolean analysis and standard phylogenetic methods using artificially evolved and natural mt-tRNA sequences from great apesEszter Ari, Péter Ittzés, János Podani, et al.
Urologie (Heidelberg, Germany)|December 29, 2023
[Urinary diversion with or without simple cystectomy as a salvage option for benign diseases of the lower urinary tract]Malin A Lutz, Quynh Chi Le, Matthias Müller, et al.
Biology|October 23, 2021
Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer CellsIgor Tsaur, Anita Thomas, Eva Juengel, et al.
The Prostate|January 29, 2026
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical ProstatectomyCarolin Siech, Tonio Brüggemann, Quynh Chi Le, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Urologia Internationalis|March 6, 2024
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial CarcinomaSéverine Banek, Mike Wenzel, Benedikt Lauer, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2025
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable modelCarolin Siech, Helge von Kriegstein, Mike Wenzel, et al.
European Urology Oncology|May 29, 2025
Influence of Concomitant Androgen Deprivation Therapy and Its Duration for Salvage Radiation After Radical Prostatectomy: A Systematic Review and Network Meta-analysis According to Published DataQuynh Chi Le, Carolin Siech, Benedikt Hoeh, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
Pageof 5